Literature DB >> 6251261

Transformation-defective mutants of feline sarcoma virus which express a product of the viral src gene.

L Donner, L P Turek, S K Ruscetti, L A Fedele, C J Sherr.   

Abstract

Mink cell cultures infected with the Snyder-Theilen strain of feline sarcoma-leukemia virus were cloned from single cells under conditions favoring single virus-single cell interactions. The primary colonies included (i) typical feline sarcoma virus (FeSV)-transformed nonproducer clones, one of which segregated revertants, and (ii) FeSV-infected, phenotypically normal clones, three of which spontaneously converted to the transformed phenotype. The revertants and spontaneous transformants were compared with parental and sister clones expressing the opposite phenotype. Transformed subclones formed colonies in agar, were tumorigenic in nude mice, and failed to bind epidermal growth factor, whereas flat sister subclones were indistinguishable from uninfected mink cells in each of these assays. Sister subclones derived from the same infectious event contained FeSV proviruses integrated at the same molecular site, regardless of which phenotype was expressed. One revertant clone, however, lacked most FeSV proviral DNA sequences but retained terminal portions of the FeSV genome which persisted at the original site of proviral DNA insertion. Two flat subclones expressed viral RNA and the phosphorylated "gag-x" polyprotein (pp78gag-x) encoded by the gag and src sequences of the FeSV genome. Both of these clones were susceptible to retransformation by FeSV. Although unable to induce foci, the viruses rescued from these cells contained as much FeSV RNA as the focus-forming viruses rescued from transformed sister subclones and could be retransmitted to mink cells, again inducing FeSV gene products without signs of morphological transformation. We conclude that these FeSV genomes represent transformation-defective mutants.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251261      PMCID: PMC288788     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Mink cell line Mv 1 Lu (CCL 64). Focus formation and the generation of "nonproducer" transformed cell lines with murine and feline sarcoma viruses.

Authors:  I C Henderson; M M Lieber; G J Todaro
Journal:  Virology       Date:  1974-07       Impact factor: 3.616

2.  Transformation-defective virus mutants in a class of morphologic revertants of sarcoma virus transformed nonproducer cells.

Authors:  J S Greenberger; G R Anderson; S A Aaronson
Journal:  Cell       Date:  1974-08       Impact factor: 41.582

3.  Revertants of mouse cells transformed by murine sarcoma virus. 3. Metastable expression of virus functions in revertants retransformed by murine sarcoma virus.

Authors:  P J Fischinger; S Nomura; N Tuttle-Fuller; K J Dunn
Journal:  Virology       Date:  1974-05       Impact factor: 3.616

4.  A nuclease specific for heat-denatured DNA in isolated from a product of Aspergillus oryzae.

Authors:  T Ando
Journal:  Biochim Biophys Acta       Date:  1966-01-18

5.  Magnesium precipitation of ribonucleoprotein complexes. Expedient techniques for the isolation of undergraded polysomes and messenger ribonucleic acid.

Authors:  R D Palmiter
Journal:  Biochemistry       Date:  1974-08-13       Impact factor: 3.162

6.  Repeated sequences in DNA. Hundreds of thousands of copies of DNA sequences have been incorporated into the genomes of higher organisms.

Authors:  R J Britten; D E Kohne
Journal:  Science       Date:  1968-08-09       Impact factor: 47.728

7.  Transmissible feline fibrosarcoma.

Authors:  S P Snyder; G H Theilen
Journal:  Nature       Date:  1969-03-15       Impact factor: 49.962

8.  Production of mouse mammary tumor virus by cultured cells in the absence and presence of hormones: assay by molecular hybridization.

Authors:  G Ringold; E Y Lasfargues; J M Bishop; H E Varmus
Journal:  Virology       Date:  1975-05       Impact factor: 3.616

9.  Transplantable murine tumors release mouse-tropic and xenotropic type-C viruses.

Authors: 
Journal:  Int J Cancer       Date:  1975-04-15       Impact factor: 7.396

10.  Simple, quantitative assay for both xenotropic murine leukemia and ecotropic feline leukemia viruses.

Authors:  P J Fischinger; C S Blevins; S Nomura
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

View more
  16 in total

Review 1.  Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.

Authors:  Jiao Zhang; Yan-Hua Chen; Qun Lu
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

2.  Excision of copia element in a revertant of the white-apricot mutation of Drosophila melanogaster leaves behind one long-terminal repeat.

Authors:  B D Carbonare; W J Gehring
Journal:  Mol Gen Genet       Date:  1985

3.  Monoclonal antibodies specific to transforming polyproteins encoded by independent isolates of feline sarcoma virus.

Authors:  F Veronese; G J Kelloff; F H Reynolds; R W Hill; J R Stephenson
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

4.  Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-Ib) provirus with a deletion in pX-I.

Authors:  L Ratner; S F Josephs; B Starcich; B Hahn; G M Shaw; R C Gallo; F Wong-Staal
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

5.  Revertants and partial transformants of rat fibroblasts infected with Fujinami sarcoma virus.

Authors:  B Mathey-Prevot; M Shibuya; J Samarut; H Hanafusa
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

6.  Structure of the feline c-fes/fps proto-oncogene: genesis of a retroviral oncogene.

Authors:  A J Roebroek; J A Schalken; C Onnekink; H P Bloemers; W J Van de Ven
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

7.  Differences in mechanisms of transformation by independent feline sarcoma virus isolates.

Authors:  F H Reynolds; W J Van de Ven; J Blomberg; J R Stephenson
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

8.  Transformation-defective mutants of Snyder-Theilen feline sarcoma virus lack tyrosine-specific protein kinase activity.

Authors:  M Barbacid; L Donner; S K Ruscetti; C J Sherr
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

9.  McDonough feline sarcoma virus: characterization of the molecularly cloned provirus and its feline oncogene (v-fms).

Authors:  L Donner; L A Fedele; C F Garon; S J Anderson; C J Sherr
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

10.  Recombinant bacteriophages containing the integrated transforming provirus of Gardner--Arnstein feline sarcoma virus.

Authors:  L A Fedele; J Even; C F Garon; L Donner; C J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.